Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

MannKind Corporation: A Simple But Intelligent Elucidation Of The Sanofi Partnership Deal

|Includes:MannKind Corporation (MNKD), SNY

Published at Retail Investor 360: Monday, 18 August 2014 15:52Written by Doctor Hung V. Tran, MD, MS. Disclosure: We are long MNKD.

Editorial Introduction. On August 11, 2014, MannKind disclosed the company had entered into a partnership agreement with the French global diabetes leader, Sanofi. Despite this positive development, the market has been highly negative on the news, perhaps due to confusions regarding the accounting/corporate terms of the deal. Many market participants just don't get it! MannKind now has command of vast armies of Sanofi sales and marketing reps to ultra rapidly deliver Afrezza to 28 million patients with diabetes in the U.S. alone.

If you'd like to read more, please follow this LINK!

Stocks: MNKD, SNY